Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
149
datasets available to search
ShareScore release 0.9.0
Dataset results
149 results for “vedolizumab”
Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab
ClinicalTrials.gov study NCT03500653. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
An Open Label Phase 4 Study to Evaluate Efficacy of Early Versus Late Use of Vedolizumab in Ulcerative Colitis
ClinicalTrials.gov study NCT02646657. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Fecal Microbial Transplantation and Vedolizumab Treatment of Crohn's Disease
ClinicalTrials.gov study NCT04328922. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study
ClinicalTrials.gov study NCT02760615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pillcam Crohn's Capsule for Monitoring of Panenteric Mucosal Healing in Crohn's Disease Patients With Vedolizumab
ClinicalTrials.gov study NCT03889613. IPD Sharing: NO. Countries: 1. Publications: 0.
Vedolizumab Post Op Study
ClinicalTrials.gov study NCT02834754. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Infliximab or Vedolizumab in Treating Immune Checkpoint Inhibitor-Related Colitis in Patients With Genitourinary Cancer or Melanoma
ClinicalTrials.gov study NCT04407247. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After
ClinicalTrials.gov study NCT06815003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis
ClinicalTrials.gov study NCT06475820. IPD Sharing: NO. Countries: 1. Publications: 0.
Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis
ClinicalTrials.gov study NCT05515029. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vedolizumab Study With Inflammatory Bowel Disease Patients in Germany
ClinicalTrials.gov study NCT03375424. IPD Sharing: NO. Countries: 1. Publications: 0.
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis
ClinicalTrials.gov study NCT03679546. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating the Combined Effect of Vedolizumab and Semi-Vegetarian Diet on Ulcerative Colitis.
ClinicalTrials.gov study NCT03309865. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD)
ClinicalTrials.gov study NCT02986724. IPD Sharing: YES. Countries: 1. Publications: 0.
An Exploration of the Relationship Between Serum Cytokine Levels and the Clinical Efficacy of Vedolizumab
ClinicalTrials.gov study NCT06855862. IPD Sharing: NO. Countries: 1. Publications: 0.
Effect of Vitamin D Supplementation on Vedolizumab Response in Patients With Ulcerative Colitis
ClinicalTrials.gov study NCT05649462. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Comparison of Upadacitinib and Vedolizumab in Second-line Treatment for Crohn's Disease
ClinicalTrials.gov study NCT06446219. IPD Sharing: NO. Countries: 1. Publications: 0.
Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis
ClinicalTrials.gov study NCT04743518. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of the Effect of Vedolizumab on Intestinal Microecological Changes and Its Efficacy in the Treatment of Ulcerative Colitis
ClinicalTrials.gov study NCT05481619. IPD Sharing: YES. Countries: 1. Publications: 0.
Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis
ClinicalTrials.gov study NCT03839680. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.